Rituximab in B-cell disorders other than non-Hodgkin's lymphoma. [electronic resource]
Producer: 20030822Description: S25-33 p. digitalISSN:- 0959-4973
- Anemia, Hemolytic, Autoimmune -- drug therapy
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- therapeutic use
- B-Lymphocytes -- pathology
- Clinical Trials as Topic
- Hematologic Diseases -- drug therapy
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Lymphoma, Non-Hodgkin -- drug therapy
- Lymphoproliferative Disorders -- drug therapy
- Organ Transplantation -- adverse effects
- Paraproteinemias -- drug therapy
- Purpura, Thrombocytopenic, Idiopathic -- drug therapy
- Rituximab
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.